ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Launch of LighthouseAI, an AI-Based Venture Unit to Solve Commercial Regulatory Compliance for the Life Sciences Industry

Pharma Solutions, a leading provider of compliance services in the life sciences industry, today announced the establishment of a new corporate venture unit and product suite, LighthouseAI™.

LighthouseAI aims to solve compliance with a first-mover, AI-powered SaaS product suite that will fundamentally change the approach that the life sciences industry takes for compliance. This purpose-built technology will help reduce the risk, time, effort, and cost associated with commercial regulatory compliance through the application of its patent-pending AI engine. 

To lead this new technology and venture unit, Pharma Solutions CEO Sumeet Singh will be transitioning to CEO of LighthouseAI effective Feb. 1, 2023.  

"We simply created a better way for our clients to manage the patchwork of regulation applicable to the life sciences industry. Regulation is difficult because of the dynamic and complex landscape which consists of over 80 state agencies creating and enforcing rules based on various federal and state laws that result in over 2,000 compliance requirements. These requirements may apply to any of the 65,000 companies within the industry depending on over 100 unique attributes of the company at the facility level," says Singh. "With the development of our category-defining 'RegTech' venture unit, we aim to automate and technologically enable a historically manual, complex, and painful compliance journey."  

Singh will remain Chairman of Pharma Solutions to ensure that current levels of support for all clients and partners remain unchanged. He will pass leadership of the company to Nathan Fox, who will transition from Chief Operating Officer to President of Pharma Solutions.  

"I have worked hand in hand with Sumeet since I joined in July 2019, and together we have grown Pharma Solutions into the leading provider of compliance services in the life sciences industry. I am proud of our ability to deliver solutions that overcome key compliance challenges. Looking forward, I am wholly confident in our ability to continue our growth trajectory and maintain our relentless passion for helping clients meet their business and compliance objectives," says Fox.

Learn more about LighthouseAI and its forthcoming AI-powered product suite by joining the waitlist here: https://sneakpeek.lighthouseai.com/solving-compliance-with-ai/

About Pharma Solutions 

Since inception, Pharma Solutions has assisted over 600 companies in responding to the ever-fluctuating patchwork of state and federal compliance requirements. We offer a wide range of strategy, consulting, and technology-based solutions for the pharmaceutical supply chain industry. Our clients range from international drug manufacturers with $10 billion+ in annual revenue to family-owned pharmacies. For more information about Pharma Solutions, please visit www.pharma.solutions or email us at hello@pharma.solutions.  

About LighthouseAI 

LighthouseAI markets a single-source SaaS solution called LighthouseAI that applies AI to automate and technologically enable compliance for the life sciences supply chain to reduce costs and risk. For more information about LighthouseAI, please visit www.LighthouseAI.com or email us at hello@lighthouseai.com.

Contact Information:
Ryan Hall
Marketing Manager
ryan.hall@pharma.solutions
(610) 298-5247


Original Source: Launch of LighthouseAI, an AI-Based Venture Unit to Solve Commercial Regulatory Compliance for the Life Sciences Industry
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.